| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma. | Haematologica | 2007 | 0.84 |
| 2 | Proteasome inhibitor therapy for Waldenström's macroglobulinemia. | Clin Lymphoma Myeloma Leuk | 2013 | 0.80 |
| 3 | High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence. | Leuk Lymphoma | 2003 | 0.78 |
| 4 | Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation. | Leuk Lymphoma | 2006 | 0.75 |